๐๏ธ Verified NIH Record โข Updated 2026-03-09
EXPLORER Total Body PET/CT Imaging for Myofascial Pain (NCT05876858)
๐ต Active, Not Recruiting Early Phase1 ๐ Investigational Drug / Biologic Sponsor: University of California, Davis
๐ฉบ Plain-English Summary (8th-Grade Level)
The main objective of this study is to establish novel measures derived from Total-body-Positron Emission Tomography/Computed Tomography (TB-PET/CT) as quantitative biomarkers for the investigation of myofascial pain. The TB-PET/CT assessed measures are those reflective of myofascial tissue metabolism, perfusion, and fatty infiltration.
Who can join: Review the eligibility criteria below.
Location: University of California Davis Health โ Sacramento, California
Age range: 18 Years
๐งช Interventions in This Study
๐ "Do I Qualify?" โ 1-Minute Self Screener
Instant ChecklistFull eligibility criteria are available on the official NIH protocol. View the criteria โ
๐ All Participating Trial Locations (1 Sites)
- University of California Davis Health โ Sacramento, California
๐ฐ Cost, Insurance & Patient Rights
- 100% Free Items: The investigational treatment and protocol-required procedures are supplied at zero cost by the sponsor.
- Routine Patient Care: Under federal law (ACA ยง 2709) and many state statutes, routine care costs are covered during participation.
- Voluntary Participation: You may withdraw at any time without affecting your standard medical care.
More studies in Myofascial Pain
- Multi-modal Imaging of Myofascial Pain โ St Louis, Missouri
- Evaluation of a Novel Class of Objective Myofascial Pain Assessments โ Boston, Massachusetts
- Multi-modal Imaging of Myofascial Pain - Phase 2 โ St Louis, Missouri
Explore by condition: All Myofascial Pain clinical trials
๐ก How to Participate
- Check the checklist above to see if you may qualify.
- Review the official NIH record below to find the coordinating site.
- Ask about the visit schedule, what is covered at no cost, and any travel support.
- Confirm with your own doctor before making a decision.